Elevated mTOR signaling was evident in a DCM patient with an LMNA E161K mutation as well as in cardiomyocytes derived from mouse embryonic stem (mES) cells with the patient-specific LMNA mutation. Here, LMNA is linked to familial dilated cardiomyopathy.